As Johnson & Johnson (JNJ) Share Value Rose, Shareholder Schafer Cullen Capital Management Decreased Stake by $3.38 Million; Interocean Capital Stake in 3M Company (MMM) Has Lowered by $793,573

February 15, 2018 - By wolcottdaily

Interocean Capital Llc decreased its stake in 3M Company (MMM) by 7.94% based on its latest 2017Q3 regulatory filing with the SEC. Interocean Capital Llc sold 3,797 shares as the company’s stock rose 7.02% with the market. The hedge fund held 44,048 shares of the medical and dental instruments company at the end of 2017Q3, valued at $9.25 million, down from 47,845 at the end of the previous reported quarter. Interocean Capital Llc who had been investing in 3M Company for a number of months, seems to be less bullish one the $138.16B market cap company. The stock increased 0.28% or $0.64 during the last trading session, reaching $232. About 2.34 million shares traded. 3M Company (NYSE:MMM) has risen 18.59% since February 15, 2017 and is uptrending. It has outperformed by 1.89% the S&P500.

Schafer Cullen Capital Management Inc decreased its stake in Johnson & Johnson (JNJ) by 2.04% based on its latest 2017Q3 regulatory filing with the SEC. Schafer Cullen Capital Management Inc sold 26,002 shares as the company’s stock rose 6.85% with the market. The hedge fund held 1.25 million shares of the major pharmaceuticals company at the end of 2017Q3, valued at $162.21 million, down from 1.27 million at the end of the previous reported quarter. Schafer Cullen Capital Management Inc who had been investing in Johnson & Johnson for a number of months, seems to be less bullish one the $348.36B market cap company. The stock decreased 0.22% or $0.29 during the last trading session, reaching $129.67. About 6.26M shares traded. Johnson & Johnson (NYSE:JNJ) has risen 12.54% since February 15, 2017 and is uptrending. It has underperformed by 4.16% the S&P500.

Investors sentiment is 0.83 in Q3 2017. Its the same as in 2017Q2. It is without change, as 45 investors sold JNJ shares while 871 reduced holdings. only 111 funds opened positions while 645 raised stakes. 1.71 billion shares or 0.90% less from 1.73 billion shares in 2017Q2 were reported. 57,372 are owned by Saybrook Cap Nc. Holowesko Ptnrs owns 293,900 shares for 3.04% of their portfolio. Cypress Asset Mngmt Inc Tx reported 98,265 shares. The Maryland-based Maryland Capital Mgmt has invested 0.58% in Johnson & Johnson (NYSE:JNJ). Rhumbline Advisers, a Massachusetts-based fund reported 4.37M shares. Ally Financial invested in 15,000 shares. Arrow Finance reported 1.86% in Johnson & Johnson (NYSE:JNJ). Sigma Planning Corporation invested 0.87% in Johnson & Johnson (NYSE:JNJ). Fiduciary Tru stated it has 429,518 shares. Hodges Capital Mgmt holds 53,557 shares or 0.47% of its portfolio. Diamond Hill Capital Management owns 1,733 shares for 0% of their portfolio. Karpus Mngmt Inc stated it has 1,775 shares or 0.01% of all its holdings. Moreover, Connor Clark & Lunn has 0.49% invested in Johnson & Johnson (NYSE:JNJ) for 623,545 shares. 71,580 are owned by Rowland & Inv Counsel Adv. Bath Savings owns 24,221 shares.

Schafer Cullen Capital Management Inc, which manages about $10.62 billion and $8.31B US Long portfolio, upped its stake in Pfizer Inc. (NYSE:PFE) by 789,462 shares to 4.24M shares, valued at $151.54M in 2017Q3, according to the filing. It also increased its holding in Bae Systems Plc (Adr) (BAESY) by 121,633 shares in the quarter, for a total of 2.52 million shares, and has risen its stake in Advanced Semiconductor Enginee (NYSE:ASX).

Among 23 analysts covering Johnson & Johnson (NYSE:JNJ), 12 have Buy rating, 5 Sell and 6 Hold. Therefore 52% are positive. Johnson & Johnson had 89 analyst reports since August 7, 2015 according to SRatingsIntel. On Friday, July 21 the stock rating was downgraded by Atlantic Securities to “Sell”. The stock has “Hold” rating by Stifel Nicolaus on Wednesday, October 18. The rating was maintained by Stifel Nicolaus with “Hold” on Wednesday, January 24. Barclays Capital maintained the shares of JNJ in report on Wednesday, April 20 with “Overweight” rating. RBC Capital Markets maintained Johnson & Johnson (NYSE:JNJ) rating on Monday, July 10. RBC Capital Markets has “Buy” rating and $13800 target. The rating was maintained by RBC Capital Markets with “Buy” on Friday, September 22. The company was maintained on Sunday, August 27 by RBC Capital Markets. Jefferies maintained Johnson & Johnson (NYSE:JNJ) rating on Thursday, August 4. Jefferies has “Hold” rating and $119 target. The stock of Johnson & Johnson (NYSE:JNJ) earned “Buy” rating by Citigroup on Monday, October 23. The company was maintained on Wednesday, October 14 by S&P Research.

Since August 17, 2017, it had 0 insider buys, and 20 selling transactions for $33.77 million activity. Shin Hak Cheol sold $1.86M worth of stock. Another trade for 1,428 shares valued at $295,106 was sold by Hammes Eric D.. $4.75M worth of stock was sold by THULIN INGE G on Wednesday, January 31. Gangestad Nicholas C also sold $936,291 worth of 3M Company (NYSE:MMM) shares. 4,146 shares valued at $1.02M were sold by Roman Michael F on Friday, February 2. On Thursday, February 1 Vrohidis Ippocratis sold $56,178 worth of 3M Company (NYSE:MMM) or 225 shares.

Among 16 analysts covering 3M (NYSE:MMM), 8 have Buy rating, 3 Sell and 5 Hold. Therefore 50% are positive. 3M had 77 analyst reports since July 24, 2015 according to SRatingsIntel. The firm has “Buy” rating by Credit Suisse given on Friday, April 28. As per Wednesday, December 7, the company rating was upgraded by RBC Capital Markets. The rating was maintained by Citigroup with “Buy” on Wednesday, October 25. The firm has “Hold” rating by RBC Capital Markets given on Wednesday, October 11. On Wednesday, December 13 the stock rating was maintained by Stifel Nicolaus with “Hold”. RBC Capital Markets maintained the shares of MMM in report on Friday, July 24 with “Underperform” rating. Credit Suisse maintained 3M Company (NYSE:MMM) rating on Wednesday, October 25. Credit Suisse has “Outperform” rating and $260 target. The rating was maintained by RBC Capital Markets with “Underperform” on Tuesday, August 4. Jefferies maintained the stock with “Buy” rating in Thursday, December 14 report. The firm earned “Hold” rating on Tuesday, December 12 by RBC Capital Markets.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By1 wolcottdaily

Automatic Stock Updates

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: